Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-08-07, Stock:ABBV, The news for the past five days is as follows:
2020-07-31: NEWS1: AbbVie Earnings Top, Drug Giant Rebounds Bullishly, Flashes Buy Signal.NEWS2: AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates.NEWS3: Pharma Stock Roundup: Q2 Earnings & J&J and PFE's Coronavirus Updates in Focus.NEWS4: 5 Key Things You'll Want to Know About AbbVie's Q2 Update.NEWS5: Let's Not Overlook AbbVie's Q2 Beat.NEWS6: AbbVie Beats Earnings Expectations but Stock Falls Anyway.NEWS7: Earnings & Economic Data Deluge.NEWS8: AbbVie Shares Climb After Adjusted Profit Beats Analyst Views.NEWS9: AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates.NEWS10: AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%.NEWS11: AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales.
2020-08-03: NEWS1: AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments.NEWS2: Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial.NEWS3: AbbVie Inc.'s (NYSE:ABBV) P/E Is On The Mark.NEWS4: A Giant Pension Sold Apple and Intel Stock. Here Are Two Stocks It Bought..
2020-08-04: NEWS1: 3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term Portfolio.NEWS2: How Neurocrine Biosciences Crushed It in Q2.
2020-08-05: nan
2020-08-06: NEWS1: Early Sales of Eli Lilly's Migraine Drug Disappoint.

Answer: Rise